tiprankstipranks
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
:2289
Hong Kong Market
2289
Charmacy Pharmaceutical Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2289 full AI Analyst Report?

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Financial Statements

0 Followers

Charmacy Pharmaceutical Co., Ltd. Class H Financial Overview

Charmacy Pharmaceutical Co., Ltd. Class H's market cap is currently HK$593.46M. The company's EPS TTM is HK$0.42; its P/E ratio is 10.91; and it has a dividend yield of 6.25%. Charmacy Pharmaceutical Co., Ltd. Class H is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 4.38B¥ 4.44B¥ 4.40B¥ 4.18B¥ 3.79B
Gross Profit¥ 336.01M¥ 324.76M¥ 292.74M¥ 268.61M¥ 234.12M
Operating Income¥ 68.10M¥ 73.25M¥ 66.19M¥ 121.52M¥ 32.39M
EBITDA¥ 152.14M¥ 155.71M¥ 136.92M¥ 121.03M¥ 107.55M
Net Income¥ 46.27M¥ 53.28M¥ 51.34M¥ 90.47M¥ 23.15M
Balance Sheet
Cash & Short-Term Investments¥ 753.92M¥ 563.15M¥ 644.76M¥ 503.81M¥ 641.76M
Total Assets¥ 3.96B¥ 3.46B¥ 3.25B¥ 2.87B¥ 2.76B
Total Debt¥ 2.09B¥ 1.70B¥ 1.37B¥ 1.19B¥ 1.33B
Net Debt¥ 1.34B¥ 1.13B¥ 740.32M¥ 913.11M¥ 696.99M
Total Liabilities¥ 3.35B¥ 2.84B¥ 2.65B¥ 2.27B¥ 2.26B
Stockholders' Equity¥ 616.63M¥ 618.69M¥ 597.81M¥ 594.48M¥ 504.10M
Cash Flow
Free Cash Flow¥ 263.42M¥ 90.31M¥ -137.39M¥ 35.46M¥ -44.58M
Operating Cash Flow¥ 270.89M¥ 106.04M¥ -96.54M¥ 44.05M¥ -19.54M
Investing Cash Flow¥ -7.09M¥ -15.64M¥ 39.34M¥ 71.76M¥ -24.40M
Financing Cash Flow¥ -213.98M¥ -31.54M¥ 101.26M¥ -191.21M¥ 74.40M
Currency in CNY

Charmacy Pharmaceutical Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Charmacy Pharmaceutical Co., Ltd. Class H Debt to Assets

Balance Sheet >

Charmacy Pharmaceutical Co., Ltd. Class H Cash Flow

Cash Flow >

Charmacy Pharmaceutical Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >